Part 5/9:
For example, during Ebola’s worst outbreak, scientists and pharmaceutical companies mobilized to develop vaccines and therapies. Yet, a crucial issue arose: by the time these vaccines became available, the epidemic was already waning. This illustrates a key limitation—delays in vaccine testing and deployment can mean missed opportunities for containment, especially when outbreaks fade quickly.
Similarly, diseases like Zika have the potential to explode in outbreaks, but without prior investment in research, responses can be delayed, impacting lives and economies.